Nucleic Acids Research, 1993, Vol. 21, No. 18 4363-4368
© 1993
MOLECULAR BIOLOGY |
A topoisomerase II-like protein is part of an inducible DNA-binding protein complex that binds 5' of an immunoglobulin promoter
Oklahoma Medical Research Foundation, Department of Immunobiology and Cancer Oklahoma City, OK 73104 1SmithKline Beecham Oharmaceuticals, Department of Cellular Biochemistry King of Prussia, PA 19406, USA
Received March 29, 1993. Revised August 6, 1993. Accepted August 6, 1993.
We previously Identified a B cell-specific protein-DNA complex 5' of an Immunoglobulin n heavy chain promoter. The sequences to which this protein complex bound were required for induction of immunoglobulin mRNA levels with interleukln-5 + antigen. Further studies identified a second sequence 5' of these regulatory sequences that bound to both the nuclear matrix and to a similar lnterleukin-5 + antigen inducible protein complex. Therefore, we sought to Identify the putative regulatory proteins that comprised this DNA-blnding complex. In this study, we have used anti-topoisomerase II antibodies to demonstrate that one of the proteins found In the lnterleukin-5 + antigen inducible complexes is serologically related to topoisomerase II. To our knowledge, this Is the first report where a topoisomerase II related protein participates In an inducible mobility shifted protein-DNA complex. These data suggest a model In which the enhanced immunoglobulin gene transcription observed after treatment with Interleukln-5 + antigen might be explained by the Induction of a protein complex that acts to relieve torsional stress along the gene.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. Rajaiya, M. Hatfield, J. C. Nixon, D. J. Rawlings, and C. F. Webb Bruton's Tyrosine Kinase Regulates Immunoglobulin Promoter Activation in Association with the Transcription Factor Bright Mol. Cell. Biol., March 15, 2005; 25(6): 2073 - 2084. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Webb, Y. Yamashita, N. Ayers, S. Evetts, Y. Paulin, M. E. Conley, and E. A. Smith The Transcription Factor Bright Associates with Bruton's Tyrosine Kinase, the Defective Protein in Immunodeficiency Disease J. Immunol., December 15, 2000; 165(12): 6956 - 6965. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Malone, L. Patrone, K. L. Buchanan, C. F. Webb, and R. Wall An Upstream Oct-1- and Oct-2-Binding Silencer Governs B29 (Ig{beta}) Gene Expression J. Immunol., March 1, 2000; 164(5): 2550 - 2556. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Webb, E. A. Smith, K. L. Medina, K. L. Buchanan, G. Smithson, and S. Dou Expression of Bright at Two Distinct Stages of B Lymphocyte Development J. Immunol., May 15, 1998; 160(10): 4747 - 4754. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakano, T. Yamazaki, S. Miyatake, N. Nozaki, A. Kikuchi, and T. Saito Specific Interaction of Topoisomerase IIbeta and the CD3[IMAGE] Chain of the T Cell Receptor Complex J. Biol. Chem., March 15, 1996; 271(11): 6483 - 6489. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Morse-Gaudio and M. Risley Topoisomerase II expression and VM-26 induction of DNA breaks during spermatogenesis in Xenopus laevis J. Cell Sci., January 10, 1994; 107(10): 2887 - 2898. [Abstract] [PDF] |
||||



